The Mike Hosking BreakfastThe Mike Hosking Breakfast

Richard Roxburgh: Young kiwi to be first to trial new muscular dystrophy drug

View descriptionShare

A young kiwi patient will be one of the first to be treated with a radical new treatment for a rare disease. 

The drug will be used to target muscle cells and silence a gene which causes Facioscapulohumeral Muscular Dystrophy.

Neurologist and trial lead Richard Roxburgh says the method is promising.

 

LISTEN ABOVE

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. The Mike Hosking Breakfast

    4,558 clip(s)

The Mike Hosking Breakfast

Open your mind to the world with New Zealand’s number one breakfast radio show. Without question, a 
Social links
Follow podcast
Recent clips
Browse 4,565 clip(s)